(Q73212268)

English

Mechanisms modifying atherosclerotic disease - from lipids to vascular biology

scientific article published on 01 September 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10575056%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Mechanisms modifying atherosclerotic disease - from lipids to vascular biology (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10575056%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

author name string

P Weissberg

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10575056%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 September 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10575056%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10575056%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

147 Suppl 1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10575056%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S3-10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10575056%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Genetic manipulation of vascular adhesion molecules in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Molecular bases of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Apoptosis of vascular smooth muscle cells in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Coronary plaque disruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Platelet function in hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Angiographic progression of coronary artery disease and the development of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Progression of coronary atherosclerosis: is coronary spasm related to progression?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease: The Caerphilly and Speedwell Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Effect of atorvastatin on plasma fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Lovastatin therapy in hypercholesterolemia: effect on fibrinogen, hemorrheologic parameters, platelet activity, and red blood cell morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Effects of long-term treatment with lovastatin on the clotting system and blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Effects of lovastatin therapy on plasminogen activator inhibitor-1 antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Effect of Fluvastatin on Lipids and Fibrinolysis in Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900249-X

7 January 2021

Identifiers

10.1016/S0021-9150(99)00249-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10575056%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10575056%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73212268&oldid=1687997448"